Abstract:Influencing the redox balance of pancreatic beta cells could be a promising strategy for the treatment of diabetes. Nuclear factor erythroid 2p45-related factor 2 (Nrf2) is present in beta cells and regulates numerous genes involved in antioxidant defense. As reactive oxygen species (ROS) are important for beta cell signaling but induce oxidative stress when present in excess, this study elucidates the influence of Nrf2-activating compounds on different kinds of ROS and correlates changes in redox balance to effects on mitochondrial function, insulin release, and cell viability. Acute glucose stimulation (15 mmol/L) of murine islet cells of C57Bl/6N mice affects ROS and redox status of the cells differently. Those ROS monitored by dihydroethidium, which detects superoxide radical anions, decrease. By contrast, oxidant status, monitored by dichlorodihydrofluorescein, as well as intracellular H 2 O 2 , increases. Glucolipotoxicity completely prevents these fast, glucose-mediated alterations and inhibits glucose-induced NAD(P)H production, mitochondrial hyperpolarization, and ATP synthesis. Oltipraz (10 μ mol/L) or dimethyl fumarate (DMF, 50 μ mol/L) leads to nuclear accumulation of Nrf2, restores mitochondrial activity and glucose-dependent ROS turnover, and antagonizes glucolipotoxicity-induced inhibition of insulin release and apoptosis. Importantly, these beneficial effects only occur when beta cells are challenged and damaged by high lipid and carbohydrate supply. At physiological conditions, insulin release is markedly reduced in response to both Nrf2 activators. This is not associated with severe impairment of glucose-induced mitochondrial hyperpolarization or a rise in apoptosis but coincides with altered ROS handling. In conclusion, Nrf2 activators protect beta cells against glucolipotoxicity by preserving mitochondrial function and redox balance. As our data show that this maintains glucose-stimulated insulin secretion, targeting Nrf2 might be suited to ameliorate progression of type 2 diabetes mellitus. By contrast, nonstressed beta cells do not benefit from Nrf2 activation, thus underlining the importance of physiological shifts in ROS homeostasis for the regulation of beta cell function.

Protective Role of Nuclear Factor E2-Related Factor 2 Against Acute Oxidative Stress-Induced Pancreatic Β -Cell Damage.

Nrf2 in Type 2 Diabetes and Diabetic Complications: Yin and Yang

Cnc-Bzip Protein Nrf1-Dependent Regulation of Glucose-Stimulated Insulin Secretion

Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance

Suppression of NADPH oxidase 2 substantially restores glucose-induced dysfunction of pancreatic NIT-1 cells.

Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells

Nrf2: Therapeutic Target of Islet Function Protection in Diabetes and Islet Transplantation.

The Role of Thioredoxin/Peroxiredoxin in the β-Cell Defense Against Oxidative Damage

Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in Type 2 diabetes

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy

Deletion of Thioredoxin Reductase Disrupts Redox Homeostasis and Impairs β-Cell Function

Oxidative Stress in Pancreatic Beta Cell Regeneration

NADPH Oxidase 2-Derived Reactive Oxygen Species Mediate FFAs-induced Dysfunction and Apoptosis of Β-Cells Via JNK, P38 MAPK and P53 Pathways.

The protective roles of Eugenol on type 1 diabetes mellitus through NRF2 mediated oxidative stress pathway

Inhibition of the Keap1/Nrf2 Signaling Pathway Significantly Promotes the Progression of Type 1 Diabetes Mellitus

Protective Role of NRF2 in Macrovascular Complications of Diabetes

Oxidative stress suppresses PHB2‐mediated mitophagy in β‐cells via the Nrf2/PHB2 pathway

Nrf2 protects against diabetic dysfunction of endothelial progenitor cells via regulating cell senescence

Neuroprotective Effects of an Nrf2 Agonist on High Glucose-Induced Damage in HT22 Cells

Oxidative Stress in Cytokine-Induced Dysfunction of the Pancreatic Beta Cell: Known Knowns and Known Unknowns

Redox Status as a Key Driver of Healthy Pancreatic β-Cells